If you have read every self-help book and constantly find yourself in and out of therapy, then it's time to consider how ...

Brian Dean is a retired nurse and a volunteer contract manager with United Methodist Church Estate and Patio Sales. Two years ...

The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

Secondary rectal cancer tumors that develop years after prostate cancer radiation therapy appear to differ in distinct ways from primary rectal cancers.

Would you take a call during a visit? Are you self-conscious about your hairy legs? Keep your doctor happy and focused by ...

Discover how NeuroSAFE improves erectile function and early continence recovery post-prostate surgery, benefiting patients.

Kidney stones and gallstones may increase the risk for prostate cancer, which could have implications for disease monitoring and prevention in specific populations. Patients with kidney stones or ...

A team of top specialists from MIOT International Hospital Chennai comprising Dr Sanjeev Velayudhan Nair (nephrologist), Dr Ramanitharan Manikandan (urology/transplant surgeon), and Dr Subbannan ...

The University of Miami Health System, for example, recently opened a medical center in Doral, HCA Florida Healthcare has ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer pre-chemotherapy. Just six days ...

NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Georgia Urology, recently disclosed that it suffered a data breach that compromised the ...

The radiopharmaceutical lutetium 177 can be used after radium 223 to treat metastatic castration-resistant prostate cancer.